Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults.
Status: Enrolling
Updated:  12/31/1969
mi
from
Denekamp,
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults.
Status: Enrolling
Updated: 12/31/1969
mi
from
Denekamp,
Click here to add this to my saved trials
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated:  12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated: 12/31/1969
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated:  12/31/1969
New York University School of Medicine
mi
from
New York, NY
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated: 12/31/1969
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated:  12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated:  12/31/1969
UMHAT "Alexandrovska"
mi
from
Sofia,
Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sialic Acid Extended-Release Tablets in Patients With GNE Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)
Status: Enrolling
Updated: 12/31/1969
UMHAT "Alexandrovska"
mi
from
Sofia,
Click here to add this to my saved trials
Brain Connectivity Supporting Language Recovery in Aphasia
Brain Connectivity Supporting Language Recovery in Aphasia
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Brain Connectivity Supporting Language Recovery in Aphasia
Brain Connectivity Supporting Language Recovery in Aphasia
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Neuromuscular Research Center of Arizona
mi
from
Phoenix, AZ
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Neuromuscular Research Center of Arizona
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Florida Shands Hospital
mi
from
Gainesville, FL
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Florida Shands Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital of Atlanta
mi
from
Atlanta, GA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Iowa Children's Hospital
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Shriners Hospital for Children
mi
from
Portland, OR
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Shriners Hospital for Children
mi
from
Portland, OR
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
St. Louis Children's Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Rare Disease Research Center
mi
from
Atlanta, GA
Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
An Open-Label, Multi-Center Study to Evaluate the Safety, Efficacy and Tolerability of Eteplirsen in Early Stage Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Rare Disease Research Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture
Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture
Status: Enrolling
Updated:  12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture
Pain With Trigger Finger Injection: A Comparison of Steroid Alone Versus Steroid/Lidocaine Mixture
Status: Enrolling
Updated: 12/31/1969
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Strength Training in Duchenne Muscular Dystrophy
Development of a Strength Training Protocol in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Strength Training in Duchenne Muscular Dystrophy
Development of a Strength Training Protocol in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Status: Enrolling
Updated:  12/31/1969
OHSU Parkinson Center & Movement Disorder Program
mi
from
Portland, OR
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy
Status: Enrolling
Updated: 12/31/1969
OHSU Parkinson Center & Movement Disorder Program
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Gilbert, AZ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Long Beach, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Newport Beach, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Pasadena, CA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Colorado Springs, CO
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Danbury, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Danbury, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Fairfield, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Fairfield, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Stamford, CT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Stamford, CT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Atlantis, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Hialeah, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Hialeah, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Avon, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Avon, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Franklin, IN
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Franklin, IN
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #146
mi
from
Lexington, KY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #146
mi
from
Lexington, KY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Kansas City, MO
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Great Falls, MT
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Great Falls, MT
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Site #140
mi
from
Reno, NV
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Site #140
mi
from
Reno, NV
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
New Brunswick, NJ
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
White Plains, NY
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
White Plains, NY
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Mooresville, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Mooresville, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Raleigh, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Raleigh, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Winston-Salem, NC
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated:  12/31/1969
Acorda Investigational Site
mi
from
Corvallis, OR
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Status: Enrolling
Updated: 12/31/1969
Acorda Investigational Site
mi
from
Corvallis, OR
Click here to add this to my saved trials